SARS-COV-2
Clinical trials for SARS-COV-2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 trials appear
Sign up with your email to follow new studies for SARS-COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Baby vaccine trial halted: COVID shot tested in infants
⭐️ VACCINE ⭐️ TerminatedThis study tested a COVID-19 vaccine (mRNA-1273.214) in healthy infants aged 12 weeks to under 6 months. The goal was to check safety and how well the vaccine works. The study was stopped early, and only 68 babies took part.
Matched conditions: SARS-COV-2
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:50 UTC
-
COVID-19 antibody combo study halted early
Disease control TerminatedThis study tested a combination of two antibodies (REGN14256 and imdevimab) in adults with mild COVID-19 who were not at high risk for severe illness. The goal was to see if the treatment was safe and could reduce the amount of virus in the body. The study was stopped early, and …
Matched conditions: SARS-COV-2
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:39 UTC
-
HIV drug fails to prevent COVID in High-Risk healthcare workers
Prevention TerminatedThis study tested whether a daily pill (TAF/FTC), normally used for HIV, could prevent COVID-19 in healthcare workers at high risk of exposure. About 1,378 participants were randomly assigned to receive the drug or a placebo. The trial was terminated early, and the results did no…
Matched conditions: SARS-COV-2
Phase: PHASE3 • Sponsor: Hospital Italiano de Buenos Aires • Aim: Prevention
Last updated May 15, 2026 11:53 UTC